FMP
VolitionRx Limited
VNRX
AMEX
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating samples for more accurate diagnosis; and Nu.Q Discover, a solution to profiling nucleosomes. The company operates Nucleosomics a technology platform for blood test. VolitionRx Limited is based in Austin, Texas.
0.46 USD
-0.0399 (-8.67%)
Free Cash Flow
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
13.43k
90.03k
306.39k
775.3k
1.23M
2.34M
4.44M
8.43M
16M
30.36M
Revenue %
-
570.25
240.3
153.04
59.1
89.78
89.78
89.78
89.78
Operating Cash Flow
-16.46M
-20.85M
-15.28M
-18.06M
-25.89M
-2.34M
-4.44M
-8.43M
-16M
-30.36M
Operating Cash Flow %
-122.57k
-23.16k
-4.99k
-2.33k
-2.1k
-100
-100
-100
-100
Cap Ex
-1.94M
-973.56k
-1.57M
-1.08M
-277.5k
-1.98M
-3.75M
-7.12M
-13.52M
-25.66M
Cap Ex %
-14.45k
-1.08k
-512.47
-139.78
-22.5
-84.5
-84.5
-84.5
-84.5
Free Cash Flow
-18.41M
-21.83M
-16.85M
-19.15M
-26.17M
-4.32M
-8.2M
-15.55M
-29.52M
-56.02M
